DNAse/RNAse-free water was purchased from Fisher Scientific, Inc. (Pittsburgh, PA) and used for all buffers and for the stock solutions of oligonucleotides. RNase HII from E. coli was purchased from New England Biolabs (Ipswich, MA). RO was custom-made by TriLink BioTechnologies, Inc. (San Diego, CA) and additionally purified by HPLC using JASCO X-LC HPLC system (Easton, MD). All other oligonucleotides were obtained from Integrated DNA Technologies, Inc. (Coralville, IA) and used without purification (desalted). The oligonucleotides were dissolved in water and stored at -20 o C until needed. Stock concentrations of oligonucleotides were calculated by measuring the absorption of the solutions at 260 nm using a Perkin-Elmer Lambda 35 UV/VIS spectrometer (San Jose, CA). Fluorescent spectra were recorded on a Perkin-Elmer (San Jose, CA) LS-55 Luminescence Spectrometer equipped with a Hamamatsu Xenon lamp. Experiments were performed at excitation wavelength of 485 nm. Emission of FAM was monitored at 517 nm. Excitation and emission slits were 5 nm and 20 nm, respectively. The data were processed using Microsoft Excel. RNase HII-assisted binary probe assay was performed for 1 h at 30 o C in a solution containing 1×ThermoPol buffer (20 mM Tris-HCl, pH 8.8; 10 mM (NH 4 ) 2 SO 4 ,10 mM KCl, 25 mM MgCl 2 , 0.1% Triton X-100). The concentration of RO was 10 nM. The concentrations of both strands α and β were 100 nM. RNase HII was added in the amount of 10U per 130 L reaction mixture. The concentration of the analyte was 2 nM for the time-course experiments, and 0.1-3 nM for the sensitivity experiments. To determine the limit of detection (LOD) of the assay, seven independent measurements of the probe's fluorescence in the absence of the analyte (blank) were performed. The fluorescence correspondent to the LOD was calculated as the average fluorescence of the blank plus three standard deviations.
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Table S1
Oligonucleotides used in the study In lane 1, there is a single band, which corresponds to the intact RO. These data indicate that RO is stable to RNase HII degradation under the assay condition. The same band is observed when the probe is incubated in the absence of the analyte (lane 3). Addition of the HCV-DNA analyte, which is complementary to analyte-binding arms of strands and degradation of OR into product 1, the shortest fluorescent oligonucleotide fragment (lane 4). The same FAM-containing fragment is observed when RO is incubated with RNase HII and the complementary oligonucleotide (lane 2), or when RO was subjected to alkaline cleavage (lane 5). These results prove the suggested scheme for the enzyme-assisted binary probe operation (Scheme 1B). Specifically, the quadripartite complex of RO, strands and HII. The completely cleaved (0.2 M NaOH at 37 o C overnight) RO was mixed with the intact RO in definite proportions to obtain cleavage degree (α) of 0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9 and 1 and incubated in 1×ThermoPol buffer (20 mM Tris-HCl, pH 8.8; 10 mM (NH 4 ) 2 SO 4 ,10 mM KCl, 25 mM MgCl 2 , 0.1% Triton X-100) in the presence of HCV strands and (100 nM) and HCV-DNA (2 nM) for 20 min. The fluorescence intensities of the mixtures at 517 nm were used to calculate F/F 0 ratio, where F 0 is the fluorescence of intact RO and F is the fluorescence of a sample containing definite amount of the completely cleaved OR. F/F 0 values were plotted against α. The linear correlation of these values was found. The data are average of three independent experiments. The error bars are given as standard deviations.
